Microbubble-mediated ultrasound enhances the lethal effect of gentamicin on planktonic Escherichia coli

Han-Xiao Zhu1, Xun-Zi Cai1, Zhong-Li Shi1

  • 1Department of Orthopaedic Surgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, No. 88 Jiefang Road, Hangzhou 310009, China.

Insights

Microbubble-mediated ultrasound significantly boosted gentamicin's effectiveness against E. coli. This approach enhanced bacterial cell membrane permeability, leading to greater bacterial death.

Area of Science:

  • Microbiology
  • Acoustic Cavitation
  • Antimicrobial Resistance

Background:

  • Low-intensity ultrasound previously enhanced gentamicin's effect on E. coli.
  • The potential of microbubble-mediated ultrasound to further improve this antimicrobial efficacy was unexplored.

Purpose of the Study:

  • To investigate if microbubble-mediated low-intensity ultrasound enhances gentamicin's antimicrobial efficacy against planktonic E. coli.
  • To analyze the impact on bacterial counts, minimal inhibitory concentration, and cell membrane integrity.

Main Methods:

  • Planktonic E. coli (ATCC 25922) were subjected to four groups: control, microbubble only, ultrasound only, and microbubble-mediated ultrasound.
  • Ultrasound (100 mW/cm(2), 46.5 KHz) was applied.
  • Bacterial counts were determined by plate counting after 12 hours.
  • Bacterial micromorphology was assessed using transmission electron microscopy (TEM).

Main Results:

  • Microbubble-mediated ultrasound (GMUS) reduced viable E. coli counts by 1.01–1.42 log10 CFU/mL compared to ultrasound alone (GUS).
  • The minimal inhibitory concentration (MIC) of gentamicin was lower (1 μg/mL) in GMUS and GUS groups versus control and microbubble-only groups (2 μg/mL).
  • TEM revealed increased bacterial cell membrane destruction and thickness in the GMUS group.

Conclusions:

  • Microbubble-mediated low-intensity ultrasound significantly enhances the antimicrobial efficacy of gentamicin against E. coli.
  • Acoustic cavitation induced by microbubble-ultrasound likely increases bacterial cell membrane permeability, facilitating gentamicin entry.
  • This synergistic approach offers a promising strategy for combating E. coli infections.

Related Concept Videos

Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
102
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
85
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
381
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
211